Publications by authors named "George Chi"

Claim this Profile
R
Regeneration of a deactivated surface functionalised polyacrylonitrile supported Fenton catalyst for use in wastewater treatment.
Caroline A Akinremi, Sanaa Rashid, Pushpa D Upreti, George T Chi, Katherine Huddersman

RSC Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS).
Amos Olusegun Abioye, George Tangyie Chi, Elena Simone, Zoltan Nagy

Int J Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On clinical trials with a high placebo response rate.
George Y H Chi, Yihan Li, Yanning Liu, David Lewin, Pilar Lim

Contemp Clin Trials Commun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen-cationic dextran conjugate crystanules.
Amos Olusegun Abioye, Adeola Kola-Mustapha, George Tangyie Chi, Sunday Ilya

Int J Pharm· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
Qing Liu, George Y H Chi

J Biopharm Stat· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A method for testing a prespecified subgroup in clinical trials.
Yang Song, George Y H Chi

Stat Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ion chromatography technique for the rapid identification and quantification of saturated and unsaturated low molecular weight organic acids formed during the Fenton oxidation of organic pollutants.
George T Chi, Katherine D Huddersman

J Chromatogr A· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Yong-Cheng Wang, Gang Chen, George Y H Chi

J Biopharm Stat· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some issues with composite endpoints in clinical trials.
George Y H Chi

Fundam Clin Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypotheses and type I error in active-control noninferiority trials.
Gang Chen, Yong-Cheng Wang, George Y H Chi

J Biopharm Stat· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concerns.
Rajeshwari Sridhara, Gang Chen, George Y H Chi, Donna J Griebel

J Biopharm Stat· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industry, government, and academic panel discussion on multiple comparisons in a "real" phase three clinical trial.
Peter Bauer, George Chi, Nancy Geller, A Lawrence Gould, David Jordan

J Biopharm Stat· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and analysis of non-inferiority mortality trials in oncology.
Mark Rothmann, Ning Li, Gang Chen, George Y H Chi, Robert Temple

Stat Med· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis